9-Cis-Retinoic Acid

Spezifikationen

5300-03-8CAS-Nummer

610-929-9EG-Nummer

(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acidIUPAC-Name

C20H28O2Chemische Formel

300.4 g/molMolekulargewicht

9-CIS-RETINOIC ACID; Alitretinoin; 5300-03-8; Panretin; 9-cis-Tretinoin; Panrexin; 9-cis Retinoic Acid; Panretyn; Panretin Gel; 9(Z)-Retinoic acid; Retinoic acid, 9-cis-; alitretinoina; alitretinoine; alitretinoinum; Atragen; Effederm; ALRT-1057; 9 Cis Retinoic Acid; 9-cis-RA; ALRT1057; DTXSID6040404; BAL-4079; LGD-1057; AGN 192013; AGN-192013; NSC-659772; LGD1057; LG-100057; 1UA8E65KDZ; 9-CRA; b-Retinoic acid; LG100057; Retinoic acid, cis-9,trans-13-; (2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; AGN192013; (7E,9Z,11E,13E)-retinoic acid; Aberela; Avitoin; (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid; DTXCID4020404; CHEBI:50648; NSC659772; (2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid; 9cRA compound; Retinoicacid-9-cis; Retinoic acid 9-cis-; RefChem:57005; D11AH04; L01XX22; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-trans-4-trans-6-cis-8-trans-nonatetraenoic Acid; Toctino; (9cis)-retinoic acid; Alitretinoin [USAN]; Panretin (TN); (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid; trans-Vitamin a acid; Alitretinoin (USAN); 9-cis- retinoic acid; MFCD00270072; CHEMBL705; Retinova; Retin A (TN); LGD 100057; (2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid; trans-Retinoate; beta-Retinoate; Tretinoin (TN); Tretinoine [INN-French]; Tretinoinum [INN-Latin]; all-trans-b-Retinoic acid; Tretinoina [INN-Spanish]; Tretinoino [INN-Spanish]; ALRT 1057; Isotretinoin Retinoic acid; [3H]9-cis-retinoic acid; tretinoine (French) (EINECS); Isotretinoin EP Impurity D; [3H]-9-cis-retinoic acid; 9C-RA; Acide retinoique (French) (DSL); 15-Apo-beta-caroten-15-oic acid; B-retinoate; BML2-E06; CCRIS 7098; 9-Retinoate; 9-Retinoic acid; HSDB 7186; 2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)-; Isotretinoin retinoate; All-trans-b-retinoate; NSC 659772; retinoic acid, 9-cis; Ro-04-4079; 9-(Z)-retinoic Acid; Tretinoin (JAN/USP); alpha-acido (argentina); All-trans-beta-retinoate; Spectrum5_001935; ALITRETINOIN [MI]; Retinoic acid 9-cis-form; Retinoic acid, (9cis)-; 9-CIS-RETINOICACID; ALITRETINOIN [INN]; UNII-1UA8E65KDZ; ALITRETINOIN [HSDB]; alpha-vitaminsyre [denmark]; ALITRETINOIN [VANDF]; all-trans- Vitamin A1 acid; SCHEMBL18666; ALITRETINOIN [MART.]; BSPBio_001495; Tretinoin/all-trans retinoate; Tretinoin [USAN:BAN:INN]; ALITRETINOIN [WHO-DD]; 15-Apo-beta-caroten-15-oate; Alitretinoin [USAN:INN:BAN]; GTPL2645; GTPL5383; orb1987229; ALITRETINOIN [EMA EPAR]; UPCMLD-DP097:001; UPCMLD-DP097:002; BDBM31892; 9-cis-Retinoic-acid/Alitretinoin; ALITRETINOIN [ORANGE BOOK]; GLXC-10365; HMS1361K17; HMS1791K17; HMS1989K17; HMS3402K17; Tox21_302195; EBC-26528; LMPR01090022; AKOS005622553; 9-CRA. 9-cis-RA. ALRT1057; CCG-208266; DB00523; FR11993; IDI1_033965; RETINOIC ACID 9-CIS-FORM [MI]; 9-cis-Retinoic acid, >=98% (HPLC); NCGC00161590-01; NCGC00161590-02; NCGC00161590-03; NCGC00161590-04; NCGC00161590-05; NCGC00161590-06; NCGC00161590-07; NCGC00255697-01; AS-83566; HY-15128; CAS-5300-03-8; TRETINOIN IMPURITY D [EP IMPURITY]; CS-0003780; ISOTRETINOIN IMPURITY D [EP IMPURITY]; NS00070820; R1777; D02815; F88246; T21497; EN300-21037381; F242660; SR-05000013784; Q3611854; SR-05000013784-1; BRD-K35483542-001-02-3; Isotretinoin EP Impurity D; Tretinoin EP Impurity D; (2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl) nona-2,4,6,8-tetraenoic AcidSynonyme